GB1532351A - Substituted anilino-2-oxazolines and thiazolines - Google Patents
Substituted anilino-2-oxazolines and thiazolinesInfo
- Publication number
- GB1532351A GB1532351A GB11158/77A GB1115877A GB1532351A GB 1532351 A GB1532351 A GB 1532351A GB 11158/77 A GB11158/77 A GB 11158/77A GB 1115877 A GB1115877 A GB 1115877A GB 1532351 A GB1532351 A GB 1532351A
- Authority
- GB
- United Kingdom
- Prior art keywords
- thiazolines
- oxazolines
- substituted anilino
- compounds
- image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Substituted anilino-2-oxazolines and -thiazolines of the general formula <IMAGE> in which R, R1, R2, R3, Y, X1, X2 and Z have the meaning stated in Claim 1, are prepared by cyclisation of compounds of the general formula <IMAGE> in which Q is a reactive group. The compounds have antihypertensive effects.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/668,385 US4081547A (en) | 1974-12-02 | 1976-03-19 | Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension |
US05/731,236 US4103018A (en) | 1976-10-12 | 1976-10-12 | 2-[4-(Polyhalo-2-hydroxy-2-propyl)anilino]-2-oxazolin-4-ones and thiazolin-4-ones corresponding thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1532351A true GB1532351A (en) | 1978-11-15 |
Family
ID=27099887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB11158/77A Expired GB1532351A (en) | 1976-03-19 | 1977-03-16 | Substituted anilino-2-oxazolines and thiazolines |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS52113960A (en) |
AU (1) | AU506147B2 (en) |
CH (1) | CH626356A5 (en) |
DE (1) | DE2711330A1 (en) |
FR (1) | FR2344548A1 (en) |
GB (1) | GB1532351A (en) |
IE (1) | IE44791B1 (en) |
IL (1) | IL51669A (en) |
NL (1) | NL7702846A (en) |
-
1977
- 1977-03-16 CH CH325377A patent/CH626356A5/en not_active IP Right Cessation
- 1977-03-16 JP JP2913177A patent/JPS52113960A/en active Pending
- 1977-03-16 IL IL51669A patent/IL51669A/en unknown
- 1977-03-16 DE DE19772711330 patent/DE2711330A1/en not_active Withdrawn
- 1977-03-16 IE IE578/77A patent/IE44791B1/en unknown
- 1977-03-16 NL NL7702846A patent/NL7702846A/en unknown
- 1977-03-16 FR FR7707851A patent/FR2344548A1/en active Granted
- 1977-03-16 GB GB11158/77A patent/GB1532351A/en not_active Expired
- 1977-03-17 AU AU23355/77A patent/AU506147B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IE44791L (en) | 1977-09-19 |
AU2335577A (en) | 1978-09-21 |
FR2344548B1 (en) | 1978-12-29 |
AU506147B2 (en) | 1979-12-13 |
IL51669A (en) | 1980-10-26 |
DE2711330A1 (en) | 1977-09-22 |
CH626356A5 (en) | 1981-11-13 |
JPS52113960A (en) | 1977-09-24 |
IL51669A0 (en) | 1977-05-31 |
IE44791B1 (en) | 1982-04-07 |
NL7702846A (en) | 1977-09-21 |
FR2344548A1 (en) | 1977-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7908727L (en) | FOSFINYLALKANOYLPROLINER | |
ES477695A1 (en) | Derivatives of dehydrocyclicimino acids | |
ES483311A1 (en) | Mercaptoacyl derivatives of substituted prolines | |
ES485104A1 (en) | Cyclosporin derivatives, their production and pharmaceutical compositions containing them | |
SE8704599L (en) | TEOBROMINDERIVAT | |
GB1544872A (en) | 4-hydroxyphenylalkanolamine derivatives and preparation thereof | |
AU578395B2 (en) | Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkyl-pyrazoline- 3-one compounds | |
SE8001818L (en) | MERKAPTOACYLDIHYDROPYRAZOLKARBOXYLSYRADERIVAT | |
KR930703312A (en) | Preparation method of azabicyclo [2.2.2] octane-3-imine and intermediate for preparing same | |
IE791943L (en) | Phenyl quinolizidines. | |
CH612427A5 (en) | Process for the preparation of heterocyclic compounds substituted by acylamino groups | |
ES466590A1 (en) | Substituted oxadiazolopyrimidines | |
GB1507340A (en) | Hydroxypolyhaloisopropyl substituted ureido-compounds | |
GB1532351A (en) | Substituted anilino-2-oxazolines and thiazolines | |
DE3160803D1 (en) | Mixtures of optical brighteners | |
GB1556877A (en) | Imidazothiazoles and thiazolopyrimidines | |
GB2014178A (en) | 6/7-Halogenoanthraquinone compounds, and the production and use thereof | |
IE792067L (en) | Azatricyclic compounds | |
ES460807A1 (en) | 4,5,6,7-Tetrahalo-isoindolin-1-one derivatives | |
ES468361A1 (en) | 2-(2',2'-Dihalovinyl)-cyclobutanones and 2-(2',2',2'-trihaloethyl)-cyclobutanones | |
ES471267A1 (en) | Lower alkyl 2-tri-(lower)alkylsilylacetylene-N-carbethoxyglycinates and process for using same | |
JPS5414956A (en) | Novel 3-amino-4-homoisotwistan derivative | |
ES485992A1 (en) | Fungicidal compositions, process for their preparation and their application. | |
JPS51131875A (en) | A process for preparing novel pyrrolidine derivatives | |
SE8000298L (en) | CARBAMATE DERIVATIVES OF MERCAPTOACYL HYDROXIPROLINES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |